NIH-funded research R01 grant

Exploring how certain genetic elements influence early embryo development

Official title: Understanding functions of LTR retrotransposon activation in preimplantation development

Funded at Cincinnati Childrens Hosp Med Ctr · NIH-11097522 · Data updated 2026-11-12

This study is looking at how certain genetic elements called LTR retrotransposons help control early embryo development, especially during a key moment when genes start to turn on, which could lead to better understanding and improvements in fertility treatments for people trying to conceive.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionCincinnati Childrens Hosp Med Ctr
NIH-funded
Lab location1 site (Cincinnati, United States)
Project startJune 1, 2025
Project endMarch 31, 2030
Funding year2025
Award (this year)$401,927
NIH project number1R01HD118540-01
Project IDNIH-11097522 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for participation or benefit from this research include individuals undergoing in vitro fertilization or those interested in reproductive health.

Less likely to help

Patients who are not seeking fertility treatments or have no interest in reproductive health may not receive direct benefits from this research.

What this research studies

This research investigates the role of long terminal repeat (LTR) retrotransposons in the early stages of embryo development, particularly during a critical process known as zygotic gene activation (ZGA). By examining how these genetic elements function as regulatory components, the study aims to uncover their impact on gene expression and embryonic growth. The research employs advanced genetic manipulation techniques to analyze the activation of these retrotransposons in mouse models, which may provide insights relevant to human reproductive health. Understanding these mechanisms could help address issues related to embryo viability in assisted reproductive technologies.

Why it matters

Potential benefit: If successful, this research could lead to improved outcomes for embryos in in vitro fertilization, potentially reducing the rate of embryo arrest.

How similar studies have gone: Previous research has shown that understanding genetic regulation in early development can lead to significant advancements in reproductive medicine, suggesting potential success for this approach.

Where this research is happening

  • Cincinnati Childrens Hosp Med Ctr
    Cincinnati, United States
    Active

Researchers

  • Principal investigator: Chen, Zhiyuan — Cincinnati Childrens Hosp Med Ctr
  • Study coordinator: Chen, Zhiyuan

Related research

Other NIH-funded projects on the same topics.

  • Accelerating Rheumatic Heart Disease Prevention in Uganda

    A program to find people with rheumatic heart disease in Ugandan communities and give them preventive care close to home.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11645314

  • Enhanced surveillance network to track childhood vaccines and viral infections in kids

    A nationwide pediatric surveillance network will closely watch how common viruses and vaccines affect children’s health, using standard protocols at hospital and ED sites.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11624109

  • Advancing CNS drug delivery through epigenetic tweaks

    A medical research project aims to help people with lysosomal storage disorders by improving how treatments reach the brain.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11617801

  • Spina Bifida Registry for Better Clinic Care

    A national registry project aims to improve care for people with spina bifida by collecting and sharing data from multidisciplinary clinics to guide evidence-based practices.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11616587

  • Hydroxyurea to help children with sickle cell anemia in Africa

    A pediatric study tests hydroxyurea treatment for young children with sickle cell anemia in several African countries to see if it can reduce illness and improve health.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11606512

  • Hydroxyurea for Children with Sickle Cell in Africa

    A pilot study tests hydroxyurea in young children with sickle cell disease across several African countries to see if it can reduce illness and hospital visits.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11606510

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.